Results 181 to 190 of about 37,814 (299)

PSS12 COST-EFFECTIVENESS ANALYSIS OF BEVACIZUMAB AND RANIBIZUMAB IN NEOVASCULARAGE-RELATED MACULAR DEGENERATION (AMD): A CLINICAL AND ECONOMIC COMPARISON OF TWO VASCULAR ENDOTHELIAL GROWTH FACTOR INHIBITOR TREATMENTS

, 2008
JJ Patel, MA Stull, Mark Bounthavong, MLD Christopher, E. Johan Foster, AP Morreale, BK Plowman, DT Boggie   +7 more
openalex   +1 more source

Ranibizumab for retinal angiomatous proliferation in age-related macular degeneration [PDF]

, 2010
K. Atmani, M. Voigt, V. Le Tien, Giuseppe Querques, G. Coscas, G. Soubrane, Eric H. Souied   +6 more
openalex   +1 more source

Intraocular Inflammation, Safety Events, and Outcomes After Intravitreal Injection of Ranibizumab, Aflibercept, Brolucizumab, Abicipar Pegol, and Faricimab for nAMD. [PDF]

J Vitreoretin Dis
Stevanovic M, Koulisis N, Chen T, Moysidis SN, Burkemper B, Toy BC, Rao NA, Eliott D, Humayun MS.   +8 more
europepmc   +1 more source

Visual acuity outcomes in ranibizumab-treated neovascular age-related macular degeneration; stratified by baseline vision [PDF]

, 2010
O. Shona, Bhaskar Gupta, Roopa Vemala, Sobha Sivaprasad   +3 more
openalex   +1 more source

Effect of Adding Dexamethasone to Continued Ranibizumab Treatment in Patients With Persistent Diabetic Macular Edema: A DRCR Network Phase 2 Randomized Clinical Trial

JAMA ophthalmology, 2018
R. Maturi, A. Glassman, Danni Liu, R. Beck, A. Bhavsar, N. Bressler, L. Jampol, M. Melia, O. Punjabi, H. Salehi-Had, Jennifer K. Sun   +10 more
semanticscholar   +1 more source

Intravitreal ranibizumab treatment of retinal angiomatous proliferation [PDF]

, 2010
Christina Kramann, Kilian Schöpfer, Katrin Lorenz, Isabella Zwiener, Bernhard Stoffelns, Norbert Pfeiffer   +5 more
openalex   +1 more source

CompaRative Safety Analysis of Innovator and BioSimilar Ranibizumab in Chorioretinal Vascular Diseases - The CRsIBS Study. [PDF]

Clin Ophthalmol
Chakraborty D, Sinha TK, Sinha S, Biswas RK, Maiti A, Boral S, Das A, Mandal S, Bhattacharya R, Dan S, Rungta D.   +10 more
europepmc   +1 more source

Interobserver variability for retreatment indications after Ranibizumab loading doses in neovascular age‐related macular degeneration [PDF]

, 2010
Carsten Framme, Georgios Panagakis, Andreas Walter, Maria Andreea Gamulescu, Wolfgang Herrmann, Horst Helbig   +5 more
openalex   +1 more source

Outcome of optic disc capillary hemangioma following intravitreal ranibizumab injection: A case report. [PDF]

J Int Med Res
Hao M, Li F, Zhao S, Wang Y, Ma S, Zhou W.   +5 more
europepmc   +1 more source

The effects of ranibizumab (Lucentis) on retinal function in isolated perfused vertebrate retina

, 2009
M. Lüke, Kai Januschowski, Julia Lüke, S. Peters, Nina Wirtz, E. Yörük, Christoph Lüke, Karl Ulrich Bartz‐Schmidt, S. Grisanti, Peter Szurman   +9 more
openalex   +2 more sources